Electric needles could replace painkiller shots for back pain
NCT ID NCT07273006
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a technique called percutaneous electrical nerve stimulation (PENS) can replace standard nerve blocks for people with chronic low back pain. PENS uses thin needles to deliver mild electrical pulses, aiming to reduce pain without drugs or steroids. The trial will enroll 82 adults with non-specific low back pain and compare immediate pain relief from PENS versus a lidocaine nerve block.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Percutaneous electrical nerve stimulation (PENS)
What this could lead to
If successful, PENS could offer a safer, non-drug alternative to nerve blocks for diagnosing and treating chronic back pain, reducing risks from steroids and large needles.
What could go wrong
This is a small, early-phase trial (82 people) comparing two procedures. PENS may not work as well as nerve blocks, and results may not apply to all back pain types.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SPECIFIC LOW BACK PAIN (NSLBP) are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Medical University of Warsaw
Warsaw, Warszawa, 02-091, Poland
Contact Phone: •••-•••-•••• Email: •••••@•••••